Bilateral Maxillary, Sphenoid Sinuses and Lumbosacral Spinal Cord Extramedullary Relapse of CML Following Allogeneic Stem Cell Transplant
-
Soudabeh Hosseini
,
Shahla Ansari
,
Parvaneh Vosough
,
Gholamreza Bahoush
,
Morteza Shamsizadeh
,
Mitra Mehrazma
,
Akbar Dorgalaleh
Abstract
Isolated extramedullary relapse of chronic myelogenous leukemia (CML) after allogeneic stem cell transplant is rare. There is a case report of a child who developed a granulocytic sarcoma of the maxillary and sphenoid sinuses and lumbosacral spinal cord mass 18 months after allogeneic bone marrow transplant for CML. He was presented with per orbital edema and neurological deficit of lower extremities and a mass lesion was found on spinal cord imaging. No evidence of hematologic relapse was identified at that time by bone marrow histology or cytogenetic. The patient died 1 month later with a picture of pneumonia, left ventricular dysfunction and a cardiopulmonary arrest on a presumed underlying sepsis with infectious etiology. Granulocytic sarcoma should be considered in the differential diagnosis of mass lesions presenting after allogeneic bone marrow transplantation for CML, even if there is no evidence of bone marrow involvement.
Bekassy AN, Hermans J, Gorin NC, et al. Granulocytic sarcoma after allogeneic bone marrow transplantation: a retrospective European multicenter survey. Bone Marrow Transplan. 1996; 17(5): 801-8.
Koc Y, Miller KB, Schenkein DP, et al. Extramedullary tumors of myeloid blasts in adults as a pattern of relapse following allogeneic bone marrow transplantation. Cancer. 1999; 85(3):608-15.
Yaghmaie M, Ghaffari SH, Ghavamzadeh A, et al. Frequency of BCR-ABL fusion transcripts in Iranian patients with chronic myeloid leukemia. Arch Iran Med. 2008; 11(3):247-51.
Kaeda J, O'shea D, Szydlo RM, et al. Serial measurement of BCR-ABL transcripts in the peripheral blood after allogeneic stem cell transplantation for chronic myeloid leukemia: an attempt to define patients who may not require further therapy. Blood. 2006; 107(10): 4171-6.
Cross NC, Feng L, Chase A, et al. Competitive polymerase chain reaction to estimate the number of. Blood. 1993 Sep 19; 82(6): 1929-36.
Gabert J, Thuret I, Lafage M, et al. Detection of residual BCR/ABL translocation by polymerase chain reaction in chronic myeloid leukaemia patients after bone-marrow transplantation. Lancet. 1989; 2(8672): 1125-8.
Radich JP, Gehly G, Gooley T, et al. Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implications in 346 patients. Blood. 1995 May 1; 85(9):2632-8.
Drobyski WR, Endean DJ, Klein JP, et al. Detection of BCR/ABL RNA transcripts using the polymerase chain reaction is highly predictive for relapse in patients transplanted with unrelated marrow grafts for chronic myeloid leukemia. Br J Haematol. 1997; 98(2): 458-466.
Mughal TI, Yong A, Szydlo RM, et al. Molecular studies in patients with chronic myeloid leukaemia in remission 5 years after allogeneic stem cell transplant define the risk of subsequent relapse. Br J Haematol. 2001; 115(3): 569-74.
Mortimer J, Blinder MA, Schulman S, et al. Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapy. J Clin Oncol. 1989; 7(1): 50-7.
Bashey A, Shepherd S, Frankel W, et al. Induction of molecular remission by donor peripheral blood leukocyte therapy in patients relapsing with extramedullary blastic phase chronic myeloid leukemia after allogeneic bone marrow transplantation. Oncol Rep. 1998; 5(1):281-6.
Au WY, Chan AC, Lie AK, et al. Isolated extramedullary relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Bone Marrow Transplant. 1998; 22(1): 99-102.
Lee JJ, Kim HJ, Kookf H, et al. Granulocytic Sarcoma as Isolated Extramedullary Relapse after Donor Lymphocyte Infusion in a Patient with CML Who Relapsed. J Korean Med Sci. 1998; 13(4):434-6.
Giannone L, Whitlock JA, Kinney MC, et al. Use of the BCR probe to demonstrate extramedullary recurrence of CGL with a T cell lymphoid phenotype following bone marrow transplantation. Bone Marrow Transplant. 1988; 3(6):631-5.
Preudhomme C, Wattel E, Lai JL, et al. Good predictive value of combined cytogenetic and molecular follow up in chronic myelogenous leukemia after non T-cell depleted allogeneic bone marrow transplantation: a report on 38 consecutive cases. Leukemia & lymphoma. 1995; 18(3-4):265-71.
Moore JC, Dennehey CF, Anavim A, et al. Multiple joint effusions associated with high‐dose imatinib therapy in a patient with chronic myelogenous leukaemia. European J Haematol. 2006; 76(5): 444-6.
| Files | ||
| Issue | Vol 10, No 2 (2016) | |
| Section | Articles | |
| Keywords | ||
| Granulocytic sarcoma Chronic myelogenous leukemia Allogeneic stem cell transplantation | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
